Alignment Healthcare, Inc. (ALHC) Price Target Analysis
Updated Jun 18, 2026
Analyst Rating: Buy
Based on 16 analysts11.3% Below Target
ALHC trades 11.3% below Wall Street's consensus target of $24.33.
Current Price$21.86
Average Target$24.33
Target
Current
Low$16.00
Median$25.00
High$30.00
Analyst Target Range
Forward P/E118.7x
(High Premium)
PEG Ratio—
Implied Growth+98.3%
(High Growth)
Analyst Spread57.5%
(Moderate)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes ALHC achieves its forward estimates and maintains a stable P/E multiple of 118.7x. This scenario reflects the blended consensus of 16 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
ALHC Price Target Analysis
Updated June 21, 2026As of June 21, 2026, Alignment Healthcare, Inc. (ALHC) has a Wall Street consensus price target of $24.33, based on estimates from 16 covering analysts. With the stock currently trading at $21.86, this represents a potential upside of +11.3%. The company has a market capitalization of $4.47B.
Analyst price targets range from a low of $16.00 to a high of $30.00, representing a 58% spread in expectations. The median target of $25.00 aligns closely with the consensus average. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, ALHC trades at a trailing P/E of -5908.1x and forward P/E of 118.7x. Analysts expect EPS to grow +98.3% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
-2.8%
Industry Consensus
Avg Forward P/E
35.2x
(Growth Premium)
Peers with Coverage
9 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 CNCCentene Corporation | $30.1B | $61.02 | $59.00 | -3.3% | Buy | 17.5x | 43 |
 MOHMolina Healthcare, Inc. | $10.2B | $195.37 | $175.55 | -10.1% | Buy | 38.0x | 38 |
 CVSCVS Health Corporation | $125.4B | $98.32 | $103.64 | +5.4% | Buy | 13.3x | 41 |
 HUMHumana Inc. | $43.3B | $360.65 | $298.50 | -17.2% | Hold | 40.8x | 44 |
 ELVElevance Health Inc. | $84.4B | $388.50 | $415.19 | +6.9% | Buy | 14.5x | 37 |
 OSCROscar Health, Inc. | $7.4B | $28.40 | $24.20 | -14.8% | Hold | 31.5x | 11 |
 CLOVClover Health Investments, Corp. | $2.6B | $5.00 | $4.47 | -10.6% | Hold | 129.2x | 9 |
 ACGLArch Capital Group Ltd. | $32.5B | $91.18 | $102.57 | +12.5% | Buy | 9.8x | 34 |
 HCAIHauchen AI Parking Management Technology Holding Co., Ltd. | $9M | $7.77 | — | — | — | — | — |
 UNHUnitedHealth Group Incorporated | $363.9B | $400.96 | $425.81 | +6.2% | Buy | 21.8x | 52 |
ALHC — Frequently Asked Questions
Quick answers to the most common questions about buying ALHC stock.
What is the ALHC stock price target for 2026?
Alignment Healthcare, Inc. (ALHC) has a consensus 12-month price target of $24.33, implying 11.3% upside from $21.86. The 16 analysts covering ALHC see moderate appreciation potential.
Is ALHC a buy, sell, or hold?
ALHC has a consensus rating of "Buy" based on 16 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $24.33 implies 11.3% upside from current levels.
Is ALHC stock overvalued or undervalued?
At a forward P/E of 118.6754x, ALHC trades at a premium valuation. The consensus price target of $24.33 (11.3% upside) suggests analysts still see growth justifying the multiple.
How high can ALHC stock go?
The most bullish Wall Street analyst has a price target of $30 for ALHC, while the most conservative target is $16. The consensus of $24.33 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover ALHC stock?
ALHC is well covered by analysts, with 16 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 13 have Buy ratings, 2 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the ALHC stock forecast?
The 12-month ALHC stock forecast based on 16 Wall Street analysts shows a consensus price target of $24.33, with estimates ranging from $16 (bear case) to $30 (bull case). The median consensus rating is "Buy".
What is ALHC's forward P/E ratio?
ALHC trades at a forward P/E ratio of 118.7x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy ALHC stock?
Wall Street analysts are optimistic on ALHC, with a "Buy" consensus rating and $24.33 price target (11.3% upside). 14 of 16 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do ALHC price targets vary so much?
ALHC analyst price targets range from $16 to $30, a 58% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $24.33 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare